首页> 外文会议>Membrane technology 2008 >THE REMOVAL OF ENDOCRINE DISRUPTING COMPOUNDS ANDPHARMACEUTICALS FROM MEMBRANE BIOREACTOR EFFLUENTBY MEMBRANE FILTRATION
【24h】

THE REMOVAL OF ENDOCRINE DISRUPTING COMPOUNDS ANDPHARMACEUTICALS FROM MEMBRANE BIOREACTOR EFFLUENTBY MEMBRANE FILTRATION

机译:膜过滤去除膜生物反应器废水中的内分泌干扰化合物和药物。

获取原文
获取原文并翻译 | 示例

摘要

This study examined the rejection of twenty-two endocrine disrupting compoundsrn(EDCs) and pharmaceutically active compounds (PhAC) from membrane bioreactorrneffluent and laboratory-grade water (Milli-Q?) by ‘loose’ and ‘tight’ nanofiltration (NF)rnmembranes as well as a reverse osmosis (RO) membrane. Rejection by the ‘tight’ NFrnmembrane was found to be most strongly correlated with individual compound log Kowrnvalues and water solubility, with the more hydrophobic compounds showing higherrnrejection. The RO membrane provided efficient EDC and PhAC removal (>90%).rnConversely, in general, the ‘loose’ NF membrane offered poor and variable compoundrnremoval. Fouling and the presence of organic matter likely contributed to higherrnrejections of EDCs and PhACs by the membranes.
机译:这项研究检查了膜生物反应器流出物和实验室级水(Milli-Q?)中22种内分泌干扰化合物(EDCs)和药物活性化合物(PhAC)的“松散”和“紧密”纳滤(NF)膜的截留率。以及反渗透(RO)膜。发现“紧密” NFrn膜的排斥与各个化合物的log log Kowrn值和水溶性的相关性最强,疏水性较高的化合物显示较高的排斥。反渗透膜可有效去除EDC和PhAC(> 90%)。相反,通常,“松散”的NF膜去除效果不佳且变化多样。污垢和有机物的存在可能导致膜对EDC和PhAC的排斥更高。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号